Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis

BACKGROUND: The risk of prostate cancer-specific mortality (PCSM) following a diagnosis of prostate cancer may improve after patients have survived a number of years after diagnosis. We sought to determine long-term conditional PCSM for patients with stage T4, N1, or M1 prostate cancer. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Muralidhar, Vinayak, Mahal, Brandon A., Nguyen, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518568/
https://www.ncbi.nlm.nih.gov/pubmed/26220664
http://dx.doi.org/10.1186/s13014-015-0470-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518568/
https://www.ncbi.nlm.nih.gov/pubmed/26220664
http://dx.doi.org/10.1186/s13014-015-0470-0

Ejemplares similares